Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

The SUN Clinical Trial (Safety Utilizing NUsurface Meniscus Implant)

A legfontosabb adatok

Ki végzi
Phoenix Kinetics
Hol
Arlington, Baton Rouge, Boulder, Denver, Greenwood, La Mesa, Long Beach, New Orleans, Phoenix, Portland, Richmond, Salt Lake City és San Francisco (Egyesült Államok)Mind a 13 helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
115 fő vett részt
Kezdés
2015. dec.
Befejezés
2024. máj. 29.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • NUsurface® Meniscus Implant
A regiszteradat frissítve
2026. augusztus 31.

Ki vehet részt

Életkor
30 év – 75 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 45 feltétel megnézéseKevesebb

Ki vehet részt

  • Had > 6 months ago a medial partial meniscectomy as confirmed by patient history and MRI
  • Has a KOOS Pain of ≤ 75 (100 being the highest attainable and no pain)
  • Is between age 30 and 75 years (inclusive) at the time of study treatment
  • Has neutral alignment ±5º of the mechanical axis, as measured from the angle formed by a line drawn from the center of the femoral head to the medial tibial spine and a line drawn from the medial tibial spine and the center of the ankle joint
  • Has ≥ 2 mm intact medial meniscal rim capable of being fitted with a NUsurface® device
  • Is able to do the study required follow-up visits, questionnaires, X-rays and MRI's
  • Is able to read and understand the English language if treated at a U.S. site or read and understand one of the official country languages if treated at a site Outside the U.S
  • Is able and willing to understand and sign the Informed Consent Form

Ki nem vehet részt

  • Has evidence of a Outerbridge Grade IV cartilage loss on the medial tibial plateau or femoral condyle that potentially could contact a NUsurface implant (e.g., a focal lesion > 0.5 cm2 correlating to a circular defect of > 8 mm in diameter)
  • Had an ACL reconstruction performed < 9 months prior to study treatment
  • Decides to receive (if eligible and an option) allograft medial meniscus transplantation
  • Received any type of prosthetic knee implant made of artificial non-resorbable plastic, metal or ceramic, not including the NUsurface® Meniscus Implant
  • Had a previous medial femoral condyle surgery (not including microfracture) or High Tibial Osteotomy (HTO)
  • Anticipates having another lower extremity surgery during the study period
  • Has received any corticosteroid knee injections ≤ 3 months prior to study treatment
  • Patients who are contraindicated for MRI (i.e., pacemaker, defibrillator, cochlear implants, etc.)
  • Has insufficiency fractures or avascular necrosis of the medial compartment
  • Has an active infection or tumor (local or systemic)
  • Has any type of knee joint inflammatory disease including Sjogren's syndrome
  • Has any medical condition that does not allow possible arthroscopy of the knee
  • Is contraindicated for corticosteroid injections (i.e., patients with allergy to any of the components or with idiopathic thrombocytopenic purpura)
  • Has ipsilateral or contralateral lower limb joint conditions that may affect ambulation or KOOS (e.g. have a leg length discrepancy > 2.5 cm [1 inch], causing a noticeable limp)
  • Is mentally incapacitated (incapable of appraising or controlling conduct) or have mental disability (e.g., dementia or Alzheimer's)
  • Is contraindicated for hyaluronic acid injections (i.e., patients with known hypersensitivity [allergy] to hyaluronan [sodium hyaluoronate] preparations); patients having knee joint infections or skin diseases or infections in the site of possible injections
  • Has a symptomatic knee because of a tear that could be addressed by a repeat partial meniscectomy leaving > 4 mm of medial meniscus rim
  • Has complete disruption of the posterior root attachment of the meniscus
  • Has lateral compartment pain and Grade III or Grade IV Outerbridge cartilage score in the lateral compartment
  • Has a varus or valgus knee deformity > 5º requiring a tibial or femoral osteotomy
  • Has a laxity level of more than Grade II (IKDC), primary or secondary to an injury of the anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or lateral collateral ligament (LCL) and/or medial collateral ligament (MCL)
  • Has significant trochlear dysplasia, patellar instability or symptomatic patellar misalignment
  • Has patellar compartment pain and Grade III or Grade IV Outerbridge cartilage score in the patellar compartment
  • Compared to a normal knee, has obvious radiological evidence of medial femoral squaring, anatomical variance in the medial tibial plateau, or irregularly shaped cartilage surface
  • Has a BMI > 32.5 at the start of study treatment
  • Has a knee flexion contracture > 10º
  • Has flexion < 90º
  • Has neuropathic knee osteoarthropathy, also known as Charcot joint
  • Has neurological deficit (sensory, motor, or reflex)
  • Is currently involved in another investigation of the lower extremity
  • Has chondrocalcinosis
  • Is on immunostimulating or immunosuppressing agents
  • Is a female who is lactating, expecting, or is intending to become pregnant during the study period
  • Is an active smoker
  • Is a prisoner
  • Is a patient who has economic incentive not to improve
  • Certain patient populations that are at high risk for poor healing or outcomes such as patients who have a co-morbidity that reduces life expectancy to less than 36 months

Helyszínek itt: Egyesült Államok

  • Arlington Orthopedic Associates, PAArlington, Egyesült Államok
  • Baton Rouge Orthopaedic ClinicBaton Rouge, Egyesült Államok
  • CU Sports MedicineBoulder, Egyesült Államok
  • Advanced Orthopaedics & Sports Medicine SpecialistsDenver, Egyesült Államok
  • OrthoIndyGreenwood, Egyesült Államok
  • Horizon Clinical ResearchLa Mesa, Egyesült Államok
  • Long Beach Memorial Medical CenterLong Beach, Egyesült Államok
  • Ochsner Sports Medicine InstituteNew Orleans, Egyesült Államok
  • Banner-University Medical Center PhoenixPhoenix, Egyesült Államok
  • Sports Medicine OregonPortland, Egyesült Államok
  • OrthoVirginiaRichmond, Egyesült Államok
  • Comprehensive Orthopaedics & Sports MedicineSalt Lake City, Egyesült Államok
  • St. Mary's Medical CenterSan Francisco, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The NUsurface® Meniscus Implant SUN Clinical Trial is a multi-center, single-arm, prospective, open label, non-randomized, observational clinical trial to gather safety and probable clinical benefit data on the NUsurface® Meniscus Implant in treated the target population.

A vizsgálat csoportja

  • NUsurface Meniscus ImplantA vizsgált kezelés

    All eligible patients will receive the NUsurface® Meniscus Implant.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
The SUN Clinical Trial (Safety Utilizing NUsurface Meniscus Implant). A Multi-center, Single-arm, Prospective, Open-label, Non-randomized, Observational Clinical Study
A regiszteradat frissítve
2026. augusztus 31.